NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.

about

NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.

Item

http://www.wikidata.org/entity/Q42356708

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.

@en

NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.

@nl

type

Item

label

NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.

@en

NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.

@nl

prefLabel

NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.

@en

NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.

@nl

P1476

NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.

@en

P2093

David W Brandes

http://www.w3.org/2001/XMLSchema#string

Kiren Kresa-Reahl

http://www.w3.org/2001/XMLSchema#string

Mark Gudesblatt

http://www.w3.org/2001/XMLSchema#string

Pamela Sater

http://www.w3.org/2001/XMLSchema#string

Richard A Sater

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

The clinical use of the MSLT and MWT

The hospital anxiety and depression scale

A new method for measuring daytime sleepiness: the Epworth sleepiness scale

Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

Prevalence of sleep problems in individuals with multiple sclerosis.

Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol.

Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients.

Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting

P304

177-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7224/1537-2073.2015-033

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27551242

http://www.w3.org/2001/XMLSchema#string

P932

4984789

http://www.w3.org/2001/XMLSchema#string